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Little is known about the long-term health-related quality of life (HRQL) and mental health outcomes for women diagnosed
with congenital adrenal hyperplasia (CAH), a disorder of sex development. Though recommendations for therapists exist, no
research has empirically investigated women’s experiences in therapy or their recommendations for therapy. Thus the purpose of
the study was to investigate HRQL, mental health concerns of women with CAH, and patients’ recommendations for therapists. A
qualitative methodology, consensual qualitative research, was used to answer these questions. Eight women with CAH participated
in the study. Results from their interviews revealed six domains: physical functioning, psychological functioning, interpersonal
processes and relationships, healthcare experiences of women with CAH, recommendations for health care professionals, and
systemic considerations. Domains were further broken down into categories with results yielding implications for both medical
and mental health professionals and shedding light on issues related to normalcy, concerns both related and unrelated to CAH,
sex, and gender, and highlighting eﬀective supports and therapeutic interventions.
1. Introduction
Conventionally referred to as intersex conditions and aﬀect-
ing an estimated 50,000 Americans [1], disorders of sex
development (DSD) and best practices of care have remained
a controversial topic in the health community. Aﬀecting
an estimated 1 in 15,000 births [2], congenital adrenal
hyperplasia (CAH) results from an inherited enzyme defi-
ciency leading to an overproduction of adrenal hormones. In
karyotpyic females (46, XX) this elevated level of androgenic
hormones impacts development in utero by virilizing or
masculinizing/defeminizing the genitalia [3]. Since CAH is
often first treated by pediatric endocrinologists, surgeons,
and urologists, research on outcomes and interventions
has primarily centered on issues most clinically relative to
these fields, specifically concerns related to sex of rearing,
psychosexual outcomes thought to influence sex assignment
such as gendered play in childhood, gender identity, and
sexual orientation (see [4], for a review) and on ethical
considerations related to treatment [5]. Thus, while CAH’s
impact on sexual and psychosexual development is well-
established in the literature, its impact on health-related
quality of life (HRQL), including mental health outcomes,
is less clear.
In recent years, a multidisciplinary approach for the
treatment of DSD has been recommended to also include
gynecological, genetic, neonatal, psychological, ethical, and
social work specialists working with children, adults, and
their families [6]. Specific to mental health specialists,
psychotherapeutic recommendations have been proposed
[7], yet little is known about what interventions are most
eﬃcacious or what specific quality of life and mental health
concerns are most salient for women diagnosed with CAH.
Thus the aim of this study was to determine the manner
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in which having CAH impacts HRQL (defined as physical,
functional, emotional, and social well-being), mental health
experience, and counseling needs for women diagnosed with
this condition.
2. Health-Related Quality of Life Specific to
Disorders of Sex Development and CAH
Although the historical focus was primarily on the medical
management of CAH, within the past thirty years research
has focused on understanding how chronic illnesses such
as CAH impact quality of life (QoL) through measures
specific to health-related quality of life (HRQL). HRQL
typically focuses on those domains of QoL that would be
directly aﬀected by one’s medical status including physi-
cal well-being (symptoms, impairments), functional well-
being (daily living, role performance), emotional well-being,
(coping, distress), and social well-being (relationship quality,
family; [8]).
Findings on HRQL specific to women with CAH have
been mixed but have generally revealed implications for
identity and relationships. One study found that women
with CAH had a significantly impaired HRQL compared
to controls [9]. This study also revealed that women with
CAH were presently engaged in fewer relationships (either
heterosexual or homosexual) than controls. Although one
must be cautious in implying that a lack of relationships
inherently denotes impaired HRQL, women with CAH have
often expressed concerns related to romantic partnerships,
specifically fears of rejection, impacted body image, and self-
esteem [10, 11]. Though Kuhnle et al., [12] revealed no sig-
nificant diﬀerences on a generic QoL measure, women with
CAH did report trends of feeling less attractive, less pleasant
in appearance, less erotic, less romantic, less feminine, and
less confident compared to age-matched control women and
were more often single, less sexually active and had less
children compared to controls. Research also finds women
with CAH have other issues relevant to their condition that
may impact their quality of life, including those related
to disclosing health-related information, weight and well-
being, as well as having a chronic life-threatening condition
[10].
Additionally, despite improving techniques, female iden-
tity may be compromised by imperfect appearing or per-
forming genitalia, even after surgery. Indeed, CAH partici-
pants reported greater amounts of pain during intercourse
[11, 13] and were only moderately satisfied with the cos-
metic appearance of their genitalia, rating their appearance
lower than physicians’ ratings [14]. Liao [15] reports that
women diagnosed with a DSD such as CAH may also have
diﬃculty disclosing about their atypical genitalia to potential
sexual partners. Shame, secrecy and stigma often accompany
ambiguous genitalia and the surgeries are, at times, framed as
“normalizing” [10]. An emphasis on normalcy [16] versus a
focus on the enjoyment of sex and intimacy may in turn lead
to anxiety and/or avoidance of sexual intimacy [15]. This
potentially explains the low rates of romantic partnerships
and sexual activity reported in the investigations of women
diagnosed with CAH [9, 11, 12, 17, 18]. Furthermore, for
women who may want to get pregnant, problems with
fertility (see [19] for a review of fertility research) may
also impact willingness to pursue relationships, and some
individuals have reported the inability to satisfy a potential
mate’s needs for children as a barrier tomarriage (C.Migeon,
personal communication, January 8, 2006).
3. Mental Health Concerns and CAH
CAH, a chronic illness that may require repeated surgeries
and challenge notions of identity and normalcy, influ-
ences those aspects of HRQL related to emotional well-
being. Nonetheless, this relationship has only recently been
explored in the literature. The sparse research on mental
health outcomes related to disorders of sex developments
in general has focused primarily on the presence of psy-
chopathology. Some evidence suggests that children with a
disorder of sex development are at risk for psychological
concerns, with roughly 40% of participants presenting with
at least one DSM-IV diagnosis and an additional 20% pre-
senting with less severe problems related to learning of their
diagnosis and/or surgical interventions [20]. Yet, findings are
mixed with another study reporting no diﬀerences between
adult participants diagnosed with a DSD and both healthy
and chronic illness control groups on measures of general
mental health, posttraumatic stress, and depression [11].
The DSD group, however, did exhibit higher trait anxiety
and lower self-esteem than unaﬀected controls, but were
no diﬀerent than those with a chronic congenital disorder
unrelated to sex development.
Similarly, findings for females diagnosed with CAH are
varied. Although some participants in one study met diag-
nostic criteria for DSM diagnoses similar to those reported
in the previous study (i.e., major depressive disorder, social
phobia, panic disorder, generalized anxiety disorder), their
overall scores on measures of depression, social adjustment,
and eating behaviors and attitudes were within normal
ranges [21]. In contrast, Johannsen et al. [9], found greater
mental distress in this population as well as greater suicidal
ideation and attempts when compared to controls. Similarly,
when compared to participants with other DSD diagnoses,
women with CAH had more suicide attempts. Women with
CAH also had significantly higher scores on an anxiety
measure, whereas participants with diﬀerent DSDs did not
diﬀer from controls. This suggests that women with CAH,
in particular, may be at a greater risk for psychopathology.
Though research has begun to explore factors associated with
poorer mental health (e.g., self-concept, personality traits,
interpersonal functioning [7]) for women with CAH, no
study has directly examined the influence of CAH on HRQL
and mental health.
4. Research on Psychotherapeutic Interventions
Though the above findings are useful in developing recom-
mendations, little is known about what empirically-based
psychotherapeutic interventions are most useful for this
population. Based on its success in reproductive medicine,
group work has been recommended for individuals with
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a DSD [15]. Individual therapy focusing on interpersonal
relationships has also been suggested [6], yet stigma exists
surrounding seeking psychological help, especially for those
diagnosed with a DSD [10]. It is thought that support
groups may be beneficial in ending stigma and isolation [6],
and some women with CAH do take advantage of them
[17]. Support for families is an additional recommendation,
as some women with a DSD report diﬃculty talking
about condition-related issues with family members [15].
This family intervention may be especially beneficial given
findings that psychopathology in individuals with a DSD
occurred twice as often among those with children and
parents who did not receive counseling at diagnosis [20].
Given the inconsistent findings for HRQL and mental
health concerns as well as limited research regarding psy-
chotherapeutic interventions for women with CAH, a qual-
itative methodology, consensual qualitative research (CQR)
[22, 23], was deemed a valuable approach to exploring these
important treatment issues. Given the history of treatment
for DSD and ethical concerns regarding treatment decision-
making, CQR was also determined to be a culturally sensitive
method in that it gives much-needed voices to individuals.
Similarly, it does not seek to present one universal under-
standing and instead provides diverse perspectives based on
the participants’ experiences; an important consideration
given diﬀerences within the population. Other authors have
also reported that interviews were more successful in helping
participants disclose thoughts and feelings regarding their
condition [24] than paper and pencil measures. CQR was
also chosen specifically for its demonstrated usefulness in
gathering a large amount of data from a small sample, as
research on this population is often constrained by small
numbers given the rarity of this condition.
5. Materials and Methods
5.1. Measures
5.1.1. Demographic Questionnaire. This included character-
istics like race, age, and so forth, as well as CAH diagnosis,
medical, surgical, and psychiatric histories.
5.1.2. SemiStructured Interview Guide. Unpublished data
from a longitudinal study [14] as well as consulta-
tions with various stakeholders informed the development
of appropriate and sensitive questions. HRQL questions
included inquiries about physical, functional, social, and
mental/emotional well-being. Given findings on social
outcomes and existing recommendations [7], questions
assessing support group use were included. Similarly, as
gaining psychotherapeutic knowledge was a goal of the
investigation, questions assessing therapy/counseling use,
experiences, and recommendations were included. Open-
ended questions were employed to promote full explanations
with prompts/probes used for clarification.
5.2. Participants. Eight participants were included, all iden-
tified as females. All identified as Caucasian or White and
ages ranged from 23 to 51 (M = 33, median = 31). Seven
were diagnosed with the salt losing form of CAH, and one
with simple virilizing type. Six participants identified as
heterosexual or straight with the two identifying as lesbian
or queer. All had at least an undergraduate degree with the
average and median years of education being 18. All had at
least one genital surgery (clitoroplasty and/or vaginoplasty,
range = 1 to 3 surgeries, median = 2), with a mean age of
3.88 years at first surgery (range = 6 to 18, median = 1). All
participants reported taking medication for CAH. Regarding
surgery/treatment, participants were treated at diﬀerent
facilities representing diverse geographic locations in the US.
Additionally, all but one participant reported a current or
past mental health concern, six sought counseling for it and
three sought counseling for issues surrounding CAH.
5.3. Procedure. Announcements were placed in DSD /Inter-
sex/CAH support groups including the Congenital Adrenal
Research Education and Support Foundation (CARES)
and the Congenital Adrenal Hyperplasia Support Forum,
through the NIH’s Clinicaltrials.gov website and a stand-
alone study website. Multiple sources were used due to
concerns about how unique clinical experiences might steer
individual towards or away from various medical, research,
or support organizations. Upon contacting the researcher,
a letter was mailed explaining the study and inclusion
criteria along with an IRB-approved consent form. The
demographic questionnaire was mailed as a follow-up. After
returning the questionnaire, participants were screened for
inclusion on the basis of self-reported diagnosis (classical
CAH), biological sex (female), and age (21–50). Geographic
location, treating-hospital/s, surgical history, severity (salt-
losing or simple virilizing), and referral method (support
group versus other) were monitored in attempts to avoid
over-representation. Participants were then contacted by the
primary investigator to set up a phone interview, lasting
approximately one hour.
5.4. Research Team. As recommended by Hill et al. [23],
prior to conducting the analysis, the team shared their
individual identity labels as well as general biases about the
topic. The team consisted of three counseling psychology
doctoral students; one identified as male, aged 30, and
two identified as female, aged 29 and 27. The auditor
was also a counseling doctoral student and identified as
female, aged 27. Two members identified as queer, one as
queer/bisexual, and another as heterosexual. Additionally,
none were diagnosed with CAH or any DSD. All were trained
in CQR and had previously been engaged in multicultural
counseling research that included its use. One had experience
working with individuals diagnosed with CAH, two noted
their pre-existing awareness of intersexuality but hoped
to increase their knowledge, whereas one reported only
having been exposed to the topic via a television program
and interactions with others on the team. Common biases
included believing that participants’ CAH-related identities
were diﬀerent than dichotomous sexuality or sex/gender
identities, that individuals may report shame surrounding
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their diagnoses/treatments, that family considerations would
be important, and that this population was, at least theoret-
ically, similar to other historically marginalized populations
in regards to mental health.
5.5. Analysis. Analysis followedmethods fromHill et al., [23]
and consisted of the following: transcription, domains, core
ideas, and cross-analysis. Each step was checked either by the
participants or an auditor with feedback then incorporated
by the team prior to continuing. First, interview transcripts
were mailed to participants for verification. Three partic-
ipants responded that the transcripts accurately reflected
their interview, and five did not respond. All transcripts
(cases) were then reviewed by the team and general thematic
domains were developed. After coding individually, team
members then met for consensus on how to split each case
into domains. Following auditing, each case was summa-
rized/paraphrased (by domain) into core ideas, with team
members taking turns leading by sharing their cores for an
entire case. The final step consisted of a cross-case-analysis
during which the team derived categories and subcategories
from all participants’ data within single domains. The team
then came to consensus about exact placement of core ideas
under each category/sub category and sent these results for
auditing. Lastly, frequencies for each category were calculated
based upon the number of cases that had core ideas within a
category.
6. Results
Six domains described the participants’ experiences and sub
jective views of how having CAH impacted their HRQL, their
mental health, and their recommendations for counseling
(Table 1). Within each domain categories revealed general,
typical, and variant themes, which, for some categories
were further clarified by sub categories. Hill et al.’s [23]
standards were used to determine frequency cutoﬀs with
general representing the majority (7-8) of cases, typical
representing more than half (6) of the cases, and variant for
less than half (2–5) but more than one case.
6.1. Physical Functioning. This domain revealed seven cate-
gories encompassing issues related to the impact of illness
and treatment on physical/physiological functioning. Gener-
ally, participants reported feeling like they were functioning
normally, a category comprised of two subcategories. The
first category, able to function well with no or minimal CAH-
related restrictions, was typical and included statements like,
“I function day to day (and) go to work like everybody else.”
The second, a variant subcategory, was normal functioning
except for having to take medication daily.
Participants generally commented on the impact of
CAH on sexual functioning, ranging from diﬃculty getting
pleasure/orgasm from sex to feeling that they could have
sex just like anyone else to stating that penetrative sex was
not an issue given the gender of their romantic partners.
Participants also generally noted an increased risk for and
sensitivity to sickness, including both a history and fear of
being sick or tired (e.g., “I was at a friend’s house. I did
not want to have them take me to the hospital. During (the)
couple of days that I was sick it was on my mind the whole
time”).
Under the general category medication, four sub-
categories emerged, all of which were typical. First were
observations regardingmedical regimens, for example, having
to take medication daily or wear a medic alert bracelet and
information regarding the level of their doses. Second were
observations about stress dosing with participants sharing
their practice or importance of altering their medications
based upon stress. Third were general side eﬀects from med-
ication, including problems with blood pressure, weakened
teeth/bones, and sleep/energy problems. One participant
noted that sensitivity to lightmade it hard for her to do things
outdoors. Lastly, a subcategory titled weight concerns from
medication included reports of weight gain, diﬃculty losing
weight, and a resulting ambivalence about medication.
Finally, within this domain there were two additional
categories that were typical in nature. The first, physical side
eﬀects of having CAH, mainly included observations about
hirsutism and short stature. Second were comments related
to adrenal crises and hospitalizations, both in childhood and
adulthood (e.g., “I had a bad crisis 4 years ago. I did not
show up for work, and when someone called and I did not
make sense they sent an ambulance. The paramedics thought
I was dead cause I was unresponsive”). Lastly, in the variant
reproductive functioning three participants noted issues with
their fertility surrounding CAH, while one stated, “I will not
be able to have kids and I do not think it’s related to CAH.”
6.2. Psychological Functioning. This domain encompassed
seven unique categories, three of which were general and
all of which described various processes related to emotions
and the mind. The first general category, processes involved
in understanding or becoming aware of CAH, described
moments of awareness and acceptance and included desires
to understand more. For example, upon reading details
about her condition, one participant stated, “In the letter
it talked about having ambiguous genitals, and I was like,
just devastated when I read that.” Other participants reported
positives including learning to accept their condition and an
ability to relate to others or increased self-awareness, as one
participant reported, “I think this thing has resulted in me
just being more aware or in tune in a good way.”
The next general category was understanding of identity
and included two opposing subcategories, both of which
were variant. On one hand, participants talked about feeling
normal, for example, “Some people see CAH as an identifier.
No, my identity is me, I have a certain job, I have a masters
degree.” Yet, participants also spoke about feeling diﬀerent
with statements such as, “I have always had this sense of not
quite fitting in and I wonder now if (CAH) contributed.”
Another general category was emotions and cognitions
related to CAH, including two subcategories, negative, which
was general, and positive, which was variant. Negative
included things like general irritability, stress, problems with
confidence, and reactions to treatment such as frustration,
anger (e.g., “I felt violated at the hospital after being vaginally
International Journal of Pediatric Endocrinology 5
Table 1: Representation of cases within each category and subcategory across each domain.
Domain/Category/Subcategory Frequency∗
Domain 1: Physical functioning general
Normal functioning general
(i) Able to function well with no or minimal CAH-related restrictions typical
(ii) Normal functioning except for having to take medication daily variant
Sexual functioning general
Increased risk for sickness general
Medication general
(i) General medical regimens typical
(ii) Stress dosing typical
(iii) General side eﬀects from medication typical
(iv) Weight concerns from medication typical
Physical side eﬀects of CAH typical
(i) Adrenal Crises and hospitalizations typical
(ii) Reproductive functioning variant
Domain 2: Psychological functioning general
Processes involved in understanding or becoming aware of CAH general
Understanding of identity general
(i) Normal variant
(ii) Diﬀerent variant
Emotions and cognitions related to CAH general
(i) Negative general
(ii) Positive variant
Mental health concerns typical
Sexuality variant
(i) Gender identity and role variant
(ii) Concentration and learning issues variant
Domain 3: Interpersonal relationships and processes general
Disclosure and others’ awareness and knowledge of CAH general
(i) Impact of CAH on others general
(ii) Interaction of CAH’s genetic component with relationships general
(iii) Utilization of support groups general
Supportive people and behaviors general
(i) Parents general
(ii) Other important relationships general
(iii) Romantic Partners typical
Unsupportive people and behaviors typical
Impact of CAH on dating typical
Having never met anyone else with CAH typical
Domain 4: Healthcare experiences of women with CAH General
Physicians general
(i) Physician’s knowledge of CAH general
(ii) Negative medical interventions general
(iii) Positive medical interventions typical
(iv) Referrals typical
Mental health clinicians: therapists, psychologists and psychiatrists general
(i) Reasons for and goals of mental health treatment/therapy general
(ii) Positive psychotherapeutic interventions general
(iii) Negative psychotherapeutic interventions variant
(iv) Clinicians’ knowledge of CAH variant
Intrapersonal processes in healthcare treatment general
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Table 1: Continued.
Domain/Category/Subcategory Frequency∗
Domain 5: Recommendations for healthcare professionals general
Helpful therapeutic traits general
The need for more education about CAH typical
(i) Things to consider when treating individuals with CAH typical
(ii) Emotional impact typical
Medical considerations typical
Connect individuals with support groups variant
The importance of access to therapeutic services variant
Domain 6: Systemic considerations general
Generational and cohort diﬀerences in women with CAH typical
Availability and appropriateness of care typical
Insurance and other financial concerns related to CAH typical
Societal biases and expectations variant
∗general = 7-8 cases, typical = 6 cases, variant = 2–5 cases.
dilated. My mom was told that I was acting like someone
who was sexually abused. I believe I was traumatized by
the procedure; it haunts me to this day”). Positive included
statements such as, “I never had any sense of shame or
anything associated with it (genital surgery).”
Typical for this domain was the category mental health
concerns, and this included participant and family mental
health and substance abuse histories. According to partic-
ipants, some concerns were directly related to CAH, (e.g.,
“(after having a second surgery) I actually did get depressed
and (was) diagnosed with depression the following summer.
(Thinking back—the psychologists and psychiatrists ask
what started it. I think that kinda started it; I felt like I could
not talk to anyone and it was not that I wanted to talk a lot
about it”), while others were unrelated (e.g., “I do not think
my bipolar was caused by the CAH, because others in my
family are bipolar and schizoaﬀective”).
The remaining data from this domain fell under three
variant categories. Sexuality included statements about
understanding both attraction (either to men, women, or
both) as well as identity (e.g., “I found out that I’m gay
and I’m very happy with that”). Gender Identity and Role
was comprised of statements including, “I sweat a lot and
I just feel like a man sometimes,” and “growing up I got
the message it was ok to be a tomboy but that I needed to
know how to be a lady too. I was taught how to cook, clean,
sew, etc.” Lastly, some participants reported concentration
and learning issues, such as, “Growing up I was hyper or I
was tired and it was just hard and focusing, sometimes I get
. . . hyper focused or I’d just totally screw around. That still
happens now.”
6.3. Interpersonal Processes and Relationships. This domain
included eight categories pertaining to interpersonal or
relational issues as a function of having CAH. Generally,
disclosure and others’ awareness and knowledge of CAH
described processes related to telling others about CAH as
well as their understanding and reactions. Some selected
whom they told (e.g., “I am socially assumed to be a man
a lot. Now, I do not correct people when they say “yes, sir”
unless it is going to be a continuing relationship”), and some
selected how much they told (e.g.,“If I travel with someone
I want them to know I carry a stress dose but that’s about
it”). Some participants seemed unsure of who actually knew
or howmuch was known about their CAH. For example, one
participant shared, “My family on my dad’s side . . . I’m sure
they knew or that they know but they do not know the extent
of what’s wrong with me and it’s untalked about because
they’re weird in the first place and . . . I think its taboo for
them. On my mom’s side of the family, they are more open.”
Also general was the impact of CAH on others. This
category included; negative feelings and experiences by
family members and friends like frustration, guilt, and
embarrassment as typified by the following quote: “He
(husband) does not like it because it’s frustrating because I’ll
go months and months being sick and there’s no light at the
end of the tunnel,” as well as no impact on friends and family.
The interaction of CAH’s genetic component with relationships
was also general and included past issues regarding heredity,
for example, “There are only two times I have seen my
parents feel guilty about passing on CAH,” as well as future
considerations such as, “I’ve thought about it and thought
about if I would be able to pass it along to my children.”
Utilization of support groups was a general category and
captured participants’ experience in or desire to be involved
in various organizations or support groups. Some partic-
ipants spoke about organizations like Congenital Adrenal
Hyperplasia Research and Support Foundation (CARES) or
congenitaladrenalhyperplasia.org with statements including,
“I think the best thing I found was this website where we all
share and now that makes me feel less alone.” Additionally,
one participant was uninterested in support groups saying,
“My endocrinologist has suggested that I go to support
groups but (I) never really thought about or felt the need.”
Supportive people and behaviors were also identified
generally within participants’ data. Three subcategories
were present with parents and other important relationships
being general and romantic relationships being typical for
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participants. Supportive parental behaviors included helping
with medical management (e.g., “Because my mom was a
nurse she was able to ask questions and keep on top of
my medications in a way I’m not sure other people would
have”) and normalizing the condition (e.g., “I really am
grateful to my parents for never making me feel odd or
sick or anything or ashamed”). Other important relationships
included siblings (e.g., “My brother’s very protective of me”),
friends (e.g., “I would have to say if I had to be at any friend’s
house, that would have been the best place to be just because
they are more mature and they would have taken care of
me if I needed it”), religion (e.g., “Going to church again
has helped me accept CAH”), and doctors (e.g., “My doctor,
my mom, and two support groups are my only support”).
Romantic relationshipswere exemplified with comments such
as, “My romantic relationship is very good.”
Unsupportive people and behaviors were also typically
present in participant interviews. Included in this category
were parents and siblings, reflected in the following state-
ment: “It really hurt me to know my siblings resented
me because I did not get abused though I know where
they’re coming from”). Also included were coworkers, as one
participant stated, “I was working with a psychiatrist who
asked me point blank, “was I trying to have a sex change,
you know, was I pre-op?,” with the facial hair and stuﬀ like
that, and I had a really good relationship with the guy but it
still just pissed me oﬀ that he said it,” and people in general,
for example, “I want people to understand where I’m coming
from, but I feel frustrated because people tell me I do not
look like I have a problem.”
Also typical was the impact of CAH on dating. Within
this category some participants reported a negative influence
(e.g., “Inmy 20s and high school it was really hard; everybody
else was dating and saying how fun it was and all of that
and I was even afraid to go out with anybody”), whereas
others reported no impact on dating. Lastly, and also typical,
participants reported having never met anyone else with CAH.
6.4. Healthcare Experiences of Women with CAH. This
domain described women’s experience with health care
(including both physical and mental health) and was com-
prised of three categories, all of which were general. The first
focused on experiences with physicians and contained several
sub categories. Comments regarding physicians’ knowledge
of CAH were general and included statements about family
doctors (e.g., “I was just lucky that my doctor knew the
condition so that he could tell that there were issues with
me”), endocrinologists (e.g., “I do not even feel that most
endocrinologists I go to know much about the condition”),
and other physicians (e.g., “I had to educate the (athletic)
team’s doctor at school because he just freaked out about
the whole idea of (me) having adrenal insuﬃciency and
the chance of getting hurt”). Also within this category
were negative medical interventions, and participants often
described physicians overmedicating patients or not listening
and ignoring. This was exemplified by one participant’s
statement, “At the time my doctor told me (the weight gain)
was not from the medication, that I was just pretty much
lazy and was eating all the time and not exercising and so,
when they finally put me on a diﬀerent medication, which
is prednisone, from there I lost all the weight.” Positive
interventions were typical and included comments such as,
“This doctor I have down here listens . . . and he understands
and he actually asked me if he could be my doctor when we
sat down and talked when I moved down here.” Also typical
were physicians’ abilities to make appropriate referrals (e.g.,
to other physicians, research studies, or support groups).
The next general category focused on experiences with
mental health clinicians including therapists, psychologists
and psychiatrists and revealed four subcategories. First,
participants generally described reasons for and goals of
mental health treatment and/or therapy. Three participants
were reportedly forced into treatment after suicide attempts
or overdoses, and participants sought treatment voluntarily
for issues both related to CAH (e.g., “The third time I
got counseling was for eating issues and CAH came up
in that when we got deeper into them”) and unrelated to
CAH (e.g., “I just got overwhelmed with work and school
and everything else, so I found a licensed therapist”). A
second general sub category described positive interventions,
including those related to CAH like accepting and exploring
CAH and its relation to other issues or simply listening and
empathizing (e.g., “It felt good to talk to someone. You
know, all the years I always held it in and did not talk to
anybody about my feelings about the health problem . . . I
felt more content after I started sharing my feelings”), as
well as those interventions unrelated to CAH (e.g., relaxation
techniques for anxiety). Negative interventions were variant
and primarily included comments about bias and lack of
understanding, (e.g., “She was very opinionated and very
judgmental, if I remember correctly. I felt like, “I do not
need to pay you to tell me to judge me.” Her job was to
help me work through whatever issues I’m dealing with”).
Lastly, and also variant, was the sub category clinicians’
knowledge of CAH, which spoke to mental health workers’
prior knowledge or lack of knowledge about CAH.
The last general category, intrapersonal processes in
healthcare treatment, encompassed participants’ internal
thoughts, feelings, and reactions within the context of
treatment. Examples included, “The only time I really think
about it (CAH) is when I go to the doctor” and “It feels funny
trying to explain to a shrink, “yeah, they built me a vagina
and they cut oﬀ my nerve center.””
6.5. Recommendations for Healthcare Professionals. This
domain included five categories of recommendations for
medical and mental health professionals. The first and only
general category was helpful therapeutic traits andwas specific
to mental health clinicians. This captured helpful traits of
therapists (e.g., “A sickly therapist who could understand
that sickness”), therapeutic approaches and techniques (e.g.,
“You still kind of have to fall back to what the individual
needs of that person are”), and foci of therapy (e.g.,
“Counseling exploring family dynamics and relationships
would be helpful”).
Two categories were typical and applied to both medical
and mental health professionals. The first, the need for
more education about CAH, emphasized the importance of
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increasing basic awareness and knowledge about the disease.
The second, things to consider when treating individuals
with CAH, went into greater detail about specific things for
professionals to be aware of and contained two subcategories.
The first emphasized the emotional impact of having CAH
(e.g., “Doctors should not dismiss emotional problems that
might be connected to CAH”). The second included com-
ments for therapists about the medical considerations related
to CAH (e.g., “Appropriate (psychotropic) medication and
when to consult an endocrinologist”).
Finally, two variant categories emphasized the need to
connect individuals with support groups (e.g., “It’d also be
good for them to have resources for you to go to. If they
were able to find a good (internet message) board, like if
you did not know about CongenitalAdrenalHyperplasia.org,
they could inform you about it and you could talk to
other people,”) and the importance of access to and timing
of therapeutic services for both individuals (e.g., “Counseling
around the time of surgery would be helpful,”) and families
(e.g., “You have two healthy parents, and then suddenly they
have got a sick baby that’s dependent on drug therapy and
mean doctors and stuﬀ, but the kid just has it; the parents
have to deal with it”).
6.6. Systemic Challenges. The last domain spoke to systemic
challenges faced by our participants and contained four
categories. The first typical category was generational and
cohort diﬀerences in women with CAH and contained par-
ticipant observations about diﬀerences between individuals
with CAH of diﬀerent ages as well as over time, as knowledge
about CAH increases. For example, some participants noted
the lack of interest in, or resources for, adults compared to
those for children, while several observed changes in how
doctors interact with patients. One participant stated, “I do
know that there was not as much information given at that
time . . . you know, as far as stress dosing. It might be that we
did not even know about it back then, that we as the patients
did not know about it. I do not know what the medical
community was doing then but there was a lot less, you know,
interactions between doctors and patients at that time.”
The next two categories, availability and appropriateness
of care and insurance and other financial concerns related to
CAH, were both typical, and related to concerns about receiv-
ing adequate health care. The first included comments about
diﬃculty finding experts, especially for adult patients/clients.
The second included statements like, “We do not make much
money so just thinking about how to financially be able to
aﬀord counseling is one thing,” and “I feel so unsafe out
here because I do not have any type of insurance.” The last
category in this domain was variant and spoke to societal
biases and expectations, including statements such as, “In our
society if you’re a little diﬀerent people look at you weird”.
7. Discussion
The aim of this study was to determine the manner in which
having CAH impacts HRQL, mental health experiences, and
counseling needs for women diagnosed with this condition.
Though findings suggest that CAH does indeed influence
aspects of all of the above, the results both confirm and
extend previous findings. Specifically, despite some common
concerns related to their condition, our participants under-
stood themselves as functioning normally. Most importantly,
they indicated that for women with CAH, feelings of
normalcy are not solely explained by physical or functional
outcomes but that the social and emotional well-being
aspects of HRQL play an important role in recommendations
for treatment. These findings provide critical information for
both medical and mental health practitioners working with
women diagnosed with CAH.
Our findings support previous results indicating that
aspects of HRQL are indeed influenced by CAH [15]. In fact,
participants shared concerns across all domains of HRQL.
However, according to the results of the current study, certain
aspects of HRQL, especially some physical concerns, may
actually be more salient of a concern for clinicians than for
individuals. For example, although the desire to maximize
fertility is something which often plays an important role
in determining the sex of a newborn with DSD, and was
a concern reported by women with CAH in another study
[7], this theme was variant, with just half of our participants
bringing up fertility and only half of those mentioning it
as a physical problem. Similarly, though research has often
focused on concerns with sexual/genital functioning (see
[14] for review), for many women in this study it was a non
issue given their satisfaction with their sexual functioning
or lack of interest in penetrative sex. Surprisingly, many
concerns which were salient to participants did not abnor-
mally impact their functioning as they saw it (e.g., having
to take medication), and women described themselves as
functioning normally both in childhood and adulthood.
They attributed this to parents, friends, and partners not
treating them as sick, to eﬀective medical interventions, and
to their own coming to terms with CAH.
The “processes involved in understanding or becoming
aware of CAH” was a blend of both positive and negative
experiences. The former were related to acceptance and sup-
port. The latter were most often associated with discovering
specifics about their history or the extremes of CAH (some-
times unintentionally as one participant did when doing
research for a school project) and were experiences that could
have been circumvented through increased education and
openness regarding the condition. In relation to social func-
tioning, results from the study provided additional support
to previous findings, which suggest that CAH does negatively
impact participants’ relationships [7, 15]. However, sup-
portive relationships were more common than unsupportive
ones in the present study, with participants emphasizing the
importance of positive, normalizing interactions between
parents, family, and partners. Similarly, though the impact
of CAH on dating was noted, most participants reported
being in very satisfying and supportive relationships, findings
which somewhat contradict those from prior research, which
found women less likely to engage in intimate relationships
[7]. For both areas, the negative impact of CAH was more
present in women’s anxiety about disclosing or in fears
of others’ reactions than actual negative responses from
others.
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Previously documented concerns regarding increased
mental illness among individuals with CAH [9] were
reflected in the results of this study. For those participants
who saw them as CAH-related, they more often attributed
them to physiological changes in mood and to external
problems with the way physicians and families handled or
disclosed CAH rather than from internal processes related to
aspects of sexual or gender identity. It is, however, important
to note that many participants saw their mental health
concerns as typical and unrelated to issues of CAH, or were
unsure of a link between CAH and their emotional or mental
health functioning. For example, it was unclear if one partic-
ipant’s substance use was a coping mechanism for negative
emotions surrounding her CAH or if it was influenced by a
family history of alcoholism or both. Similarly, though not all
participants had received counseling, all shared a wide range
of reasons and goals for counseling, the majority of which
were unrelated to CAH.
Unlike their experience with medical professionals,
which were more negative than positive, as described both
in this study and in one other [7], the reverse was true
for experiences with mental health practitioners. While
therapist’s knowledge of CAH or willingness to learn about
CAH was positive, our findings lent support for the greater
importance of the working alliance and basic helping skills.
Since issues of disclosure figured prominently in several
domains, therapist empathy, openness, and listening skills
cannot be emphasized enough. They become all the more
important in light of findings that participants had a
tendency to overlook or be reticent in telling a mental
health clinician about CAH. Similarly, participants wanted
both mental health and medical clinicians to be more
attuned to the medical implications and the impact of CAH
on emotions and mood regulation, which suggests that
general knowledge about CAH on its own is important,
but must be integrated with a tailored understanding of
the individual.
A related finding, noteworthy for practitioners working
with individuals with CAH, was that six of the eight
participants reported never having met anyone with CAH.
As consistent with previous findings [7], this is something
that contributed to feelings of isolation for the women
in this study. It is unlikely that individuals would know
others with CAH because the population is small in com-
parison to the broader population, and disclosure of this
information to others is rare. Interestingly, few participants
recommended that health care professionals connect them
with support groups, which would seem to be one solution
to deter isolation for individuals with CAH. Since many
of the women in this study strove to achieve “normal”
functioning and identities, the use of a support group may
potentially challenge this. The domain systemic considerations
included several barriers to finding individual endocrine or
therapeutic care providers which may have contributed to
women emphasizing this need over the need for support
groups and also serves as an important link between
individual relationships (e.g., between doctors and patients,
or individuals and friends) and societal norms or challenges
which may impact them.
7.1. Limitations. While attempts weremade to examine CAH
degree-or-type-specific factors related to HRQL, almost all
of our participants were diagnosed in infancy with salt
wasting type. Therefore it was not possible to highlight
trends between CAH groups. Similarly related to sampling,
participants self-selected into our study, these individuals
may be relatively healthy and interested in therapeutic issues
pertaining to CAH as compared to individuals who chose
not to participate in the study. As such, our sample may not
be representative of the broader CAH population, including
those individuals who hold strong negative feelings towards
CAH research or who do not identify strongly as a woman
with CAH. Also, much of the research on CAH exists within
a larger DSD literature base, and this study did not include
individuals with any other DSD diagnoses. As such, we are
unable to generalize beyond CAH.
8. Conclusions
8.1. Recommendations for Research. Present in our findings
was the importance of considering cohort eﬀects, which
participants attributed to the relative newness of CAH as
a disease, related changes in standards of care, and unique
needs of individuals dependent upon age. Indeed, future
research could expand upon these findings on identity in
women with CAH by further exploring variables related to
identity development processes. That being said, given the
rarity of this population, it is unlikely that recommendations
from this and other qualitative studies will be meaningfully
examined in a large enough sample of individuals with CAH
using quantitative methods. Therefore, it is recommended
that mixed methods or qualitative approaches employing
samples of practitioners or individual counseling case studies
be used in future research.
8.2. Recommendations for Medical Professionals. Perhaps the
most limiting factor for women was the way their CAH
impacted their functional well-being. Their general increased
risk for illness impacted not only the activities they could
engage in, but also everything from travel plans to choices
about where to live. This impacted other domains of HRQL
as well (e.g., socially, not wanting to be a burden on friends),
yet is something that could be improved through better
medical management and compliance. Physical concerns
regarding medication and its side eﬀects, especially weight
gain, were often exacerbated by parents and doctors who
minimized them or were hostile towards participants who
brought them up. The impact of these concerns may be
lessened by increased sensitivity and awareness on the part of
physicians, potentially leading to greater medical compliance
and, in turn, an improvement in several HRQL areas.
8.3. Recommendations for Mental Health Clinicians. Our
results remind clinicians to be mindful of their assumptions
and lend support to the primacy of the working alliance.
Several participants noted that being forced into therapy
was counterproductive towards establishing shared tasks and
goals. Indeed, therapist traits and skills (e.g., empathy and
appropriate disclosure) were more frequently mentioned
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than was therapist knowledge of CAH. Furthermore, it
is important that clinicians not assume that CAH is a
presenting concern for all individuals. Similarly, though
some participants brought up gender by mentioning that
they did indeed identify as women, only half of participants
discussed components of gender identity or role. Also, only
half discussed sexual orientation. Therefore, despite the
gendered nature of CAH, as well as some evidence suggesting
the presence of less heterosexuality in this population [25],
prior recommendations to assist clients with the examination
of their gender and sexuality [7] should be tempered with an
appreciation of individual clients’ needs. Relatedly, clinicians
should be sure to consider the diversity within this pop-
ulation, especially as it relates to terminology and identity
(e.g., intersex, DSD, CAH, gender queer) and to recognize
the importance of parallel identities (i.e., individual versus
group membership identities).
Lastly, given our findings on the role of systemic
challenges, we would like to further emphasize prior recom-
mendations [7] that clinicians consider diversity issues and
social stigma and serve as advocates for girls and women
with CAH. From improving access to care by working around
insurance limitations to challenging societal bias, there is
much that professionals can do in and out of their day-
to-day practice. Individuals with CAH are doing much to
advocate for themselves as well as to help increase medicine
and psychology’s understanding of CAH. When ending our
phone interviews, several participants shared their reasons
for participating, “I want to see something really happen. I
think that it’s . . . it’s hard, you know, just growing up with it
and I know that from my situation, and I want others to feel
more comfortable in the future,” and “I figure anything that
can help with the next generation is . . . you know, I’m here.”
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